In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cellsMarion T. Weigel, Christoph Mundhenke|BMC Cancer|2010Cited by 56
Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancerMarion T. Weigel, Lesley‐Ann Martin|Breast Cancer Research|2012Cited by 43